Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin

被引:267
作者
Hamel, E [1 ]
机构
[1] NCI, Screening Technol Branch, Dev Therapeut Program, Div Canc Treatment & Diag,NIH, Frederick, MD 21702 USA
关键词
antimitotic drugs; combretastatin A-4; docetaxel; GDP; glutamate; GTP; microtubules; paclitaxel; tubulin polymerization;
D O I
10.1385/CBB:38:1:1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Most antimitotic compounds have highly specific interactions with tubulin, the major protein component of microtubules. It is, therefore, often desirable to characterize interactions of these agents with tubulin. In particular, quantitative comparisons between new and old ("standard") agents, between different classes of agent, and between structural analogs (e.g., for a structure-activity relationship study) are important. Because antimitotic drugs have a variety of effects on tubulin and bind at multiple distinct sites on the protein, the tubulin assembly reaction is probably the only universally applicable reaction that can be analyzed. In my laboratory, we use the assembly of purified tubulin induced by higher concentrations of monosodium glutamate as our basic assay system. This report presents a detailed description of our current routine assay, including the effects of a variety of reaction components on the reaction. In addition, the variety of effects that reaction components can have on the quantitative results obtained with drugs, using the colchicine site drug combretastatin A-4 as a model compound, is described.
引用
收藏
页码:1 / 21
页数:21
相关论文
共 76 条
  • [11] Structure-activity requirements for flavone cytotoxicity and binding to tubulin
    Beutler, JA
    Hamel, E
    Vlietinck, AJ
    Haemers, A
    Rajan, P
    Roitman, JN
    Cardellina, JH
    Boyd, MR
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (13) : 2333 - 2338
  • [12] BLOKHIN AV, 1995, MOL PHARMACOL, V48, P523
  • [13] EFFECT OF MICROTUBULE-ASSOCIATED PROTEINS ON THE PROTOFILAMENT NUMBER OF MICROTUBULES ASSEMBLED INVITRO
    BOHM, KJ
    VATER, W
    FENSKE, H
    UNGER, E
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 800 (02) : 119 - 126
  • [14] BOLLAG DM, 1995, CANCER RES, V55, P2325
  • [15] BUTTLAIRE DH, 1980, J BIOL CHEM, V255, P2164
  • [16] LATTICE-DEFECTS IN MICROTUBULES - PROTOFILAMENT NUMBERS VARY WITHIN INDIVIDUAL MICROTUBULES
    CHRETIEN, D
    METOZ, F
    VERDE, F
    KARSENTI, E
    WADE, RH
    [J]. JOURNAL OF CELL BIOLOGY, 1992, 117 (05) : 1031 - 1040
  • [17] PHYSICAL AND CHEMICAL PROPERTIES OF PURIFIED TAU FACTOR AND ROLE OF TAU IN MICROTUBULE ASSEMBLY
    CLEVELAND, DW
    HWO, SY
    KIRSCHNER, MW
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1977, 116 (02) : 227 - 247
  • [18] RPR112378 and RPR115781: Two representatives of a new family of microtubule assembly inhibitors
    Combeau, C
    Provost, J
    Lancelin, F
    Tournoux, Y
    Prod'homme, F
    Herman, F
    Lavelle, F
    Leboul, J
    Vuilhorgne, M
    [J]. MOLECULAR PHARMACOLOGY, 2000, 57 (03) : 553 - 563
  • [19] CORREIA JJ, 1987, J BIOL CHEM, V262, P17278
  • [20] DOCETAXEL
    CORTES, JE
    PAZDUR, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (10) : 2643 - 2655